inadequate dialysis from decreased blood flow through the
dialyzer due to poor reexpansion of the blood pump segment and inaccurate delivery of blood at the requested blood pump speed (Bosch & Ronco, 1993; Cogan & Schoenfeld, 1991; Daugirdas & Ing, 1994; Francos et al., 1983; NKF, 1997b; Polaschegg, 1995; Twardowski et al., 1999).
I am writing in regard to the article, "
Dialyzer Reprocessing: Improved Treatment Quality and Increased
Dialyzer Reuse Using a Team Approach," published in the October 2000 issue.
Clearance of small solutes has been well characterized for both new and reused
dialyzers. While clearance of urea, creatinine, and other small solutes does decrease slightly with each subsequent use, the change is not clinically significant as long as the fiber bundle (or total cell) volume remains above 80% of its initial value for that individual
dialyzer.
The authors examined three hypotheses regarding the cause of this unexplained association: (a) progressive decrease in small and, especially, large molecule clearance; (b) a humoral response to proteins adsorbed on reused
dialyzer membranes; and (c)poor quality control of reuse procedures.
Association of
dialyzer reuse with hospitalization and survival rates among U.S.
Decreased mortality rate is probably the result of a number of factors including understanding of the role of comorbidity, treatment characteristics, barriers to adequate dialysis, nutrition, anemia, high flux dialysis,
dialyzer membrane improvement, and the desired dialysis dose (Pasten & Bailey, 1998; Port, Orzol, Held & Wolfe, 1998; Sehgal et al., 1998; Wolfe, Held, Hulbert-Shearon, Agodoa, & Port, 1998).
M2 PRESSWIRE-September 4, 2019-: Global
Dialyzer Market Projected to Reach $4.4 Billion by 2025
"The company acknowledges the Government of India's initiative to promote Make in India products and also thank the Government for reducing custom duty on parts/raw materials to make
Dialyzer (artificial kidney) used in Dialysis treatment.
For medical and non-medical reasons, several
dialyzer are being reprocessed and reused to lower hypersensitivity reactions.
Summary: For medical and non-medical reasons, several
dialyzer are being reprocessed and reused to lower hypersensitivity reactions.
This research helped inform the company's development of the Theranova
dialyzer, which is a unique type of HD therapy that extends the range of molecules that can be filtered from the blood, resulting in a clearance profile that more closely mimics the natural kidney.
It includes the use of a high-flux
dialyzer, Erythropoietin (EPO) injection, emergency medications, oxygen support, and ambulances services.